ACADIA Pharmaceuticals' GAAP loss for the 3 months of 2022 was $113.056 million, up 70.1% from $66.448 million in the previous year. Revenue increased 8.4% to $115.468 million from $106.554 million a year earlier.
ACADIA Pharmaceuticals' GAAP loss for the 3 months of 2022 was $113.056 million, up 70.1% from $66.448 million in the previous year. Revenue increased 8.4% to $115.468 million from $106.554 million a year earlier. 
ir.acadia-pharm.com
English (US) 